8 August 2021 in Journal of International Medical Research
Disseminated peritoneal leiomyomatosis (DPL), also known as leiomyomatosis peritonealis disseminata, is a rare disease characterized by multiple benign smooth muscle tumors proliferating along the peritoneal surfaces. The cause of the disease is unclear, and possible factors include iatrogenic and hormonal stimulation. The patient was a 41-year-old Chinese woman with a history of laparoscopic myomectomy and subsequent pregnancy. Multiple abdominal masses were identified and required surgical intervention. The patient had no tenderness or other discomfort. The clinical and imaging diagnosis was gastrointestinal stromal tumor, but DPL was confirmed by postoperative pathological examination. The patient had a good prognosis, and no recurrence was observed during follow-up. Iatrogenic and hormonal stimulation leading to DPL is very rare, and we believe that multiple factors led to DPL in this case. Clinicians should be aware of such potential patients.
17 May 2022 in Journal of Obstetrics and Gynaecology Research
19 August 2025 in International Journal of Surgical Pathology
Succinate dehydrogenase ( SDH )-deficient renal cell carcinoma (RCC) is a rare molecularly defined renal tumor characterized by defects in the subunit types SDHA , SDHB , SDHC , and SDHD , with most of these genetic alterations involving the SDHB subunit, whereas the SDHA , SDHC, and SDHD gene mutations are less frequent. The classic pathological features of SDH -deficient RCC include a nest-like arrangement of tumor cells containing abundant eosinophilic cytoplasm, intracytoplasmic translucent or pale inclusion bodies, and inconspicuous nucleoli. Immunohistochemistry studies have revealed SDH protein deletion with mutations in the SDH gene in this condition. This report presents a 37-year-old female patient diagnosed with SDHA -deficient RCC with a unique pathological morphology characterized mainly by papillary structures mixed with a small number of glandular tubular structures. This was finally confirmed through DNA sequencing. This tumor can be easily confused with other papillary RCCs. The patient underwent chemotherapy and targeted therapy after surgery but unfortunately died eventually. The extremely poor prognosis of the patient suggested that this group of patients should be focused on to improve the treatment and prolong their life span. Owing to the limited existing knowledge of this particular pathological type of RCC, this report would be beneficial as it provides novel insights for the diagnosis and treatment of patients with this type of tumor.
15 April 2026 in Medical Science Monitor
Phospho-Histone H3 as a Tool for Improved Mitotic Counting and Risk Assessment in Gastrointestinal Stromal Tumors: A Study of 241 Cases - Article abstract #952182